Moscow, Russia

Alina Anatolievna Busel


 

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alina Anatolievna Busel: Innovator in Pharmaceutical Sciences

Introduction

Alina Anatolievna Busel is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target critical biological pathways. With a total of two patents to her name, her work focuses on innovative treatments for various diseases.

Latest Patents

Alina's latest patents involve substituted 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide derivatives. These compounds selectively inhibit the activity of poly (ADP-ribose) polymerase PARP-1 in relation to PARP-2. The implications of her inventions are profound, as they are useful in treating diseases such as cancer, cardiovascular diseases, central nervous system injuries, and various forms of inflammation. Additionally, her patents provide methods for preparing these compounds and pharmaceutical compositions that utilize them for therapeutic purposes.

Career Highlights

Alina is currently associated with Nerviano Medical Sciences S.r.l., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on addressing unmet medical needs.

Collaborations

Alina collaborates with notable colleagues, including Gianluca Mariano, Enrico Papeo, and Alexander Khvat. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Alina Anatolievna Busel is a trailblazer in the pharmaceutical industry, with her innovative patents paving the way for new treatments. Her dedication to research and collaboration underscores her impact on medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…